Table 1 Experimental groups and dosage during treatment
From: Peptide-modified PAMAM-based bone-targeting RNA delivery system
Sr. No | Group | Number of mice | Therapeutic (Dosage) | Duration of Treatment |
|---|---|---|---|---|
1 | OVX group | 3 | Saline | 4Â weeks |
2 | PS + NC group | 3 | Negative control with PS (1 mg/kg) |  |
3 | PS + RNA group | 3 | Antagomir 138-5p with PS (1 mg/kg) |  |